Literature DB >> 12176222

Polymer based pH-sensitive carriers as a means to improve the cytoplasmic delivery of drugs.

Emmanuelle Roux1, Mira Francis, Françoise M Winnik, Jean-Christophe Leroux.   

Abstract

pH-sensitive niosomal and liposomal formulations bearing alkylated N-isopropylacrylamide (NIPAM) copolymers were characterized with regard to vesicle-polymer interaction, pH-responsiveness and stability in human serum. The interactions between the pH-sensitive NIPAM copolymer and the vesicles were studied by spectrofluorimetry, using covalently-attached pyrene as a probe. In contrast to liposomes, where complexation of copolymer to the lipid bilayer is essentially mediated by hydrophobic interactions, the binding between niosomes and PNIPAM was mainly driven by hydrogen bonding. Both formulations were found to rapidly release their contents under mildly acidic conditions. However, the niosomes lost their pH-sensitivity after incubation in serum, whereas liposomes maintained their ability to respond to pH only when complexed with a copolymer containing a high proportion of hydrophobic anchor. The ability of pH-sensitive liposome/polymer complexes to enhance the cytotoxicity of cytosine arabinofuranoside (ara-C) was evaluated in vitro using macrophage-like J774 cells. Ara-C encapsulated in pH-sensitive liposomes exhibited a higher cytotoxicity than the control formulation. This study showed that both niosomes and liposomes can be rendered pH-sensitive by anchoring a randomly-alkylated NIPAM copolymer to their surface. The interactions that take place between the polymer and the vesicles strongly depend on the vesicle nature. pH-sensitive PNIPAM-based liposomes can improve the in vitro efficiency of ara-C.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176222     DOI: 10.1016/s0378-5173(02)00183-7

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  The optimization of polymalic acid peptide copolymers for endosomolytic drug delivery.

Authors:  Hui Ding; Jose Portilla-Arias; Rameshwar Patil; Keith L Black; Julia Y Ljubimova; Eggehard Holler
Journal:  Biomaterials       Date:  2011-04-22       Impact factor: 12.479

2.  Casein maps: effect of ethanol, pH, temperature, and CaCl2 on the particle size of reconstituted casein micelles.

Authors:  Ran Ye; Federico Harte
Journal:  J Dairy Sci       Date:  2012-11-29       Impact factor: 4.034

Review 3.  Targeted pharmaceutical nanocarriers for cancer therapy and imaging.

Authors:  Vladimir P Torchilin
Journal:  AAPS J       Date:  2007-05-11       Impact factor: 4.009

Review 4.  Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.

Authors:  Vladimir Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2008-10-17       Impact factor: 5.571

Review 5.  Magnetothermally-responsive nanomaterials: combining magnetic nanostructures and thermally-sensitive polymers for triggered drug release.

Authors:  Christopher S Brazel
Journal:  Pharm Res       Date:  2008-11-13       Impact factor: 4.200

6.  Influence of polymer size, liposomal composition, surface charge, and temperature on the permeability of pH-sensitive liposomes containing lipid-anchored poly(2-ethylacrylic acid).

Authors:  Tingli Lu; Zhao Wang; Yufan Ma; Yang Zhang; Tao Chen
Journal:  Int J Nanomedicine       Date:  2012-09-13

Review 7.  Nanotechnology: intelligent design to treat complex disease.

Authors:  Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.580

8.  Synthesis, characterisation and functionalisation of BAB-type dual-responsive nanocarriers for targeted drug delivery: evolution of nanoparticles based on 2-vinylpyridine and diethyl vinylphosphonate.

Authors:  Andreas Saurwein; Andreas Schaffer; Christina Wieser; Bernhard Rieger
Journal:  RSC Adv       Date:  2021-01-05       Impact factor: 3.361

9.  Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?

Authors:  João Conde; Jesús M de la Fuente; Pedro V Baptista
Journal:  Front Pharmacol       Date:  2013-10-25       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.